LADEANA SMEDLUND: Open Payments
NPI 1871071019 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25 in 1 payment from 1 company in 2025. Trend: 2023 $8,113 · 2024 $11,997 · 2025 $25
Food & beverage: $25
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: NUCALA.
Industry payments across NE — which companies pay providers there.
